Benzoxazepin oxazolidinone compounds and methods of use
US9643980B2 · kind B2 · utility
3Cited by
7References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 2016 |
| Grant date | May 9, 2017 |
| Priority date | — |
| Expiry date | Jul 1, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are benzoxazepin oxazolidinone compounds with phosphoinositide-3 kinase (PI3K) modulation activity or function having the Formula I structure:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.